Research and Markets (http://www.researchandmarkets.com/research/9v5lft/colon) has announced the addition of the "Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016" report to their offering.

The Report, Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Colon Cancer Report is to understand the market and pipeline status of the drugs around the Colon Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies.

Key Topics Covered:

  • A snapshot of the global Market and Phase III therapeutics scenario for Colon Cancer.
  • A review of the marketed products under prescription for Colon Cancer, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.
  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
  • Product profiles for marketed products for Colon Cancer with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

Benefits of this Report:

  • Evaluate the marketing status and exclusivity details of Colon Cancer key products to exploit opportunities for generic drug development opportunities.
  • Identify and understand important and diverse types of therapeutics under Phase III development for Colon Cancer.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Colon Cancer.
  • API intelligence over leading Phase III Pipeline drugs.

Report Structure:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Colon Cancer

7. Phase III Drugs for Colon Cancer

8. Discontinued Drugs for Colon Cancer

9. Appendix

10. Methodology

11. Consulting Services

12. Contact Us

13. Disclaimer

For more information visit http://www.researchandmarkets.com/research/9v5lft/colon